Br[C:2]1[S:3][CH:4]=[C:5]([Br:7])[N:6]=1.[CH:8]12[NH:15][CH:12]([CH2:13][CH2:14]1)[CH2:11][O:10][CH2:9]2.CCN(C(C)C)C(C)C>CN(C=O)C>[Br:7][C:5]1[N:6]=[C:2]([N:15]2[CH:8]3[CH2:14][CH2:13][CH:12]2[CH2:11][O:10][CH2:9]3)[S:3][CH:4]=1To a stirred solution of 2,4-dibromothiazole (0.585 g, 2.41 mmol) in DMF (10 ml) were added 3-oxa-8-azabicyclo[3.2.1]octane (prepared according to the procedure given in WO 2010/120854, 0.3 g, 2.65 mmol) and DIPEA (0.47 gm, 0.63 ml, 3.62 mmol) under a stream of nitrogen. The reaction mixture was then stirred at 80° C. for 18 hrs and the progress of reaction was monitored by TLC. The reaction mixture was cooled to room temperature; quenched with cold water (20 ml) and extracted with ethyl acetate (3×30 ml). The combined organic layer was washed with water (2×10 ml), dried over sodium sulphate and concentrated to give crude compound; which was purified by flash column chromatography using 20% ethyl acetate in hexanes as an eluent to obtain the title compound (0.31 g, 46.7%). MS: m/z 276 (M+1).